ALK and lung adenocarcinoma: In public dataset GSE31210, low FSTL1 RNA level was associated with lung adenocarcinoma patients with ALK-fusion or KRAS mutation compared to those with EGFR mutation or EGFR/KRAS/ALK triple-negative tumors (Fig. 3d).